August 12, 2020
Session three will explore the role of implementation research to ensure effective implementation of cervical cancer prevention and control strategies.
About the series:
In 2018, according to the World Health Organization (WHO), approximately 570,000 women worldwide were diagnosed with cervical cancer. A shocking 311,000 women died of the disease. More than 80% of them were from low- and middle-income countries. While high-level institutions including the WHO are calling for action, it is crucial to understand the research, scientific advances, policy implementation considerations, and strategic coordination that are needed to reduce cervical cancer at the local and global level. A whole of society approach is required to reduce this disease, a preventable and treatable malignancy. This three-part webinar series brings together experts from the fields of research, clinical care, and policy, to debate and discuss what it will take to effectively reduce the global cervical cancer burden.
Silvina Arrossi, PhD
Centro de Estudios de Estado Sociedad, Argentina
Gina Ogilvie, MD MSc FCFP DrPH
Canada Research Chair in Global Control of HPV-Related Disease and Cancer, Senior Public Health Scientist, School of Population and Public Health, The University of British Columbia
Karla Alfaro, MD, MPH
Medical Director, Basic Health International, El Salvador
Anne F. Rositch, MSPH, PhD
Associate Professor, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, USA
Isaac F. Adewole, MD
Professor, Obstetrics and Gynaecology University of Ibadan, Nigeria